Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 288 entries
View as:

Drug-drug Interaction Study(Lobeglitazone, Warfarin)

Phase: N/A Priority: Normal
NCT ID: NCT02002611 Org: User:
Start: 12/31/13 End: 05/31/14 Due: 05/31/15

Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet

Phase: N/A Priority: Normal
NCT ID: NCT04388215 Org: User:
Start: 10/23/19 End: 04/30/21 Due: 04/30/22

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01030679 Org: User:
Start: 07/31/07 End: 10/31/08 Due: 10/31/09

Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02648854 Org: User:
Start: 10/31/15 End: 11/30/15 Due: 11/30/16

CKD-828 (40/5mg) Pharmacokinetic Study

Phase: N/A Priority: Normal
NCT ID: NCT01340131 Org: User:
Start: 01/31/11 End: 04/30/11 Due: 04/30/12

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg

Phase: N/A Priority: Normal
NCT ID: NCT04987970 Org: User:
Start: 09/12/21 End: 11/27/21 Due: 11/27/22

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Phase: N/A Priority: Normal
NCT ID: NCT03346187 Org: User:
Start: 05/19/17 End: 06/13/17 Due: 06/13/18

Safety and Pharmacokinetic Profile of CKD-581

Phase: N/A Priority: Normal
NCT ID: NCT01580371 Org: User:
Start: 05/31/12 End: 06/30/16 Due: 06/30/17

Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A

Phase: N/A Priority: Normal
NCT ID: NCT06643819 Org: User:
Start: 10/14/24 End: 12/31/26 Due: 12/31/27

Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01684605 Org: User:
Start: 10/12/12 End: 01/03/13 Due: 01/03/14

Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily

Phase: N/A Priority: Normal
NCT ID: NCT03067415 Org: User:
Start: 03/30/17 End: 09/30/17 Due: 09/30/18

Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule

Phase: N/A Priority: Normal
NCT ID: NCT01369472 Org: User:
Start: 06/30/11 End: 10/31/11 Due: 10/31/12

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04678388 Org: User:
Start: 10/29/20 End: 12/12/20 Due: 12/12/21

A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT04628143 Org: User:
Start: 12/21/20 End: 04/05/21 Due: 04/05/22

Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01756430 Org: User:
Start: 12/31/12 End: 09/30/13 Due: 09/30/14

Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT05673369 Org: User:
Start: 02/01/23 End: 02/27/23 Due: 02/27/24

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03858725 Org: User:
Start: 02/26/19 End: 05/08/19 Due: 05/08/20

Retrospective Observational Study on GERD Management in General Hospitals in Korea

Phase: N/A Priority: Normal
NCT ID: NCT06974903 Org: User:
Start: 01/03/18 End: 12/31/24 Due: 12/31/25

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05552495 Org: User:
Start: 09/23/22 End: 12/12/22 Due: 12/12/23

Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled

Phase: N/A Priority: Normal
NCT ID: NCT02526875 Org: User:
Start: 04/30/15 End: 11/30/17 Due: 11/30/18

A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04703374 Org: User:
Start: 09/25/20 End: 09/30/21 Due: 09/30/22

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.

Phase: N/A Priority: Normal
NCT ID: NCT06483243 Org: User:
Start: 04/04/24 End: 05/17/24 Due: 05/17/25

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05571813 Org: User:
Start: 11/02/22 End: 12/23/22 Due: 12/23/23

Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393

Phase: N/A Priority: Normal
NCT ID: NCT04706286 Org: User:
Start: 02/18/21 End: 04/05/21 Due: 04/05/22

CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)

Phase: N/A Priority: Normal
NCT ID: NCT02047175 Org: User:
Start: 02/28/14 End: 03/31/14 Due: 03/31/15